Tiotropium has advantages for patients with COPD

Advantages in relation to acute exacerbations, hospitalizations, symptoms and quality of life

2012-12-11

(Press-News.org) In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD), tiotropium bromide (tiotropium in brief) is one of the drugs available that can be prescribed for inhalation. The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined whether tiotropium offers a perceptible advantage to patients compared to a dummy medication (placebo) and to other COPD drugs. In addition, the two currently marketed types of inhaler (HandiHaler and Respimat) for tiotropium (trade name: Spiriva®) were compared.

According to the IQWiG report, there is proof that tiotropium offers patients with COPD advantages compared to placebo: they suffer fewer acute worsenings of their condition (exacerbations), they need to be hospitalized for this reason less often, and their quality of life is better. There are indications of a benefit in terms of less severe symptoms and complaints, e.g. breathing problems. In relation to the ability to carry out everyday practical activities, there is also a hint of a benefit of tiotropium.

An added benefit is also proven in comparison with the drugs salmeterol, formeterol, indacaterol and ipratropium: fewer exacerbations and related hospitalizations occurred under treatment with tiotropium. Compared to indacaterol there is, however, also a hint of a lesser benefit of tiotropium with regard to the COPD symptoms and quality of life.

Effects for COPD patients are the focus of interest

Tiotropium is a drug known as an "anticholinergic" that is used for the treatment of COPD, in which the airways are permanently narrowed and the lungs are damaged. The disease is characterized by chronic cough, increased sputum and shortness of breath on exercise. About 1 in 10 to 20 adults aged over 40 has COPD. Thus, the disease is much more common than asthma. Three-quarters of patients are men.

Because of the strong association with smoking, COPD is also commonly known as "smokers' cough". The outcome measures of this benefit assessment, in addition to symptoms, acute exacerbations and the resulting need for hospitalization, included mortality (deaths), health-related quality of life and side effects.

Comparison with placebo shows advantages for patients

In its worldwide search for clinical trials and systematic reviews, the Institute found a total of 27 relevant studies.

The 21 studies comparing tiotropium with a placebo produced proof of a benefit in relation to exacerbations and hospitalizations due to exacerbations. Also proven is the benefit in respect of quality of life, because the study participants using tiotropium suffered less from breathing problems and their physical health was better than in the control group. In both cases, the proof applied to both types of inhaler.

An indication of a benefit from tiotropium (again for both inhalers) could be demonstrated in relation to symptoms. For the HandiHaler, there is also a corresponding indication in terms of the mortality rate of ex-smokers.

IQWiG found a hint of a benefit for everyday practical activities. Here, the final report differed from the preliminary report because of additional data from a new study that IQWiG identified during the routine supplementary search.

Tiotropium compared to other COPD drugs

In 10 studies tiotropium was compared with other drugs, namely with ipratropium, with the combination of salmeterol and fluticasone and with the group of drugs known as "LABA". The conjoint analysis of the long-acting beta-2 sympathomimetics salmeterol, formeterol and indacaterol in the LABA group takes account of arguments from the commenting procedure on the preliminary report. As a consequence, advantages of tiotropium that are shown with one of the LABA drugs, apply to the entire group. The results of these 10 studies in general apply only to the HandiHaler inhaler, because only placebo-controlled studies were available for the Respimat.

Added benefit compared to LABA and ipratropium

Unlike in the preliminary report, the comparison with ipratropium showed not only proof of a benefit of tiotropium in relation to exacerbations, but - because of new analyses submitted during the commenting procedure - also an indication of a benefit in relation to COPD symptoms. In contrast to tiotropium and LABA, ipratropium is short-acting and must therefore be taken more often.

Proof of an added benefit of tiotropium over the LABA drug class could be demonstrated in relation to exacerbations and resulting hospitalizations.

However, compared to indacaterol there were also two hints of a lesser benefit of tiotropium, namely in respect of symptoms and quality of life. Although indacaterol belongs to the jointly considered LABA drug class, the study results vary a great deal in respect of these patient-relevant outcomes. The drugs were therefore assessed separately for the two above-named outcomes.

The comparison of tiotropium with the combination of salmeterol and fluticasone produced no differences for the patients with COPD.

No differences for other outcomes and as add-on medication

In relation to other patient-relevant outcomes such as exercise capacity, mortality, rate of cardiovascular diseases and side effects, the studies showed no differences between tiotropium and the other alternative treatments investigated.

Two studies compared the additional administration of tiotropium with the respective comparator drug alone: in one study tiotropium was added to treatment with LABA and in another study, it was given in addition to the combination of salmeterol and fluticasone. But again, no differences in benefit or harm from the additional administration of tiotropium could be derived from the results.

Evidence is basically good

The worldwide search on the topic was supplemented by requests to drug manufacturers for further studies, including unpublished ones. Boehringer Ingelheim, the sponsor of many tiotropium studies, supplied IQWiG with all the requested data and other additional information, as did the manufacturers of comparator products, GlaxoSmithKline and Novartis.

Although all studies were well-designed, some of the results could not be reliably interpreted because, for example, too many study participants were not considered in the analysis. This is why weaker conclusions about benefit, such as "indications" or "hints" were drawn, instead of "proof".

No direct comparison of the inhalers

None of the relevant studies compared the two inhalers directly with each other: there were 4 exclusively placebo-controlled studies on Respimat, while all the others were carried out with the HandiHaler.

Therefore, the respective results for the two inhalers from the placebo-controlled studies were compared with each other. The effects did not differ substantially in the studies, so that the benefit assessment based on the placebo-controlled studies in respect of almost all outcomes essentially applies also to the Respimat inhaler.

The benefit applies solely to the HandiHaler only in relation to the lower death rate of ex-smokers, because this result is based exclusively on a study conducted with this particular inhaler. The benefit assessment based on the studies comparing drugs also applies only to the HandiHaler.

Procedure of report production

IQWiG published the preliminary results in the form of the preliminary report in November 2011 and interested parties were invited to submit comments. When the commenting procedure ended, the preliminary report was revised and sent as a final report to the contracting agency, the Federal Joint Committee (G-BA), in June 2012. The written comments were published in a separate document at the same time as the final report. The report was produced in collaboration with external experts.

### END

ELSE PRESS RELEASES FROM THIS DATE:

Employers maintain training budgets despite recession, research shows

2012-12-11

British employers have avoided slashing their budgets for training during the recession because they believe it is vital to their operations, a new study has found. Researchers analysed figures from various surveys showing that spending in real terms on training fell by only 5% from 2007 to 2009, and has remained steady since. They also spoke to managers from 52 companies and found that almost all remained committed to keeping their training schemes going. In an article in the December edition of the journal Work, Employment and Society, the researchers say that "a ...

Researchers identify new components of the epigenetic 'code' for honey bee development

2012-12-11

Researchers from the UK and Australia have uncovered a new element of the honeybee's genetic makeup, which may help to explain why bees are so sensitive to environmental changes. Scientists from the University of Sheffield, Queen Mary, University of London and the Australian National University, have found that honeybees have a 'histone code' – a series of marks on the histone proteins around which their DNA is wrapped in order to fit into the nucleus of a cell. This code is known to exist in humans and other complex organisms in order to control changes in cell development ...

Does the brain become unglued in autism?

2012-12-11

Philadelphia, PA, December 11, 2012 – A new study published in Biological Psychiatry suggests that autism is associated with reductions in the level of cellular adhesion molecules in the blood, where they play a role in immune function. Cell adhesion molecules are the glue that binds cells together in the body. Deficits in adhesion molecules would be expected to compromise processes at the interfaces between cells, influencing tissue integrity and cell-to-cell signaling. In the brain, deficits in adhesion molecules could compromise brain development and communication ...

A mobile app helps children with special needs improve language and social skills

2012-12-11

University of Granada researchers have developed a cell phone that can be downloaded free from App Store and improves basic competences (maths, language, knowledge of the environment, autonomy and social skills) in children with autism-related disorders or Down Syndrome. This application--named Picaa--can be used on iPhone, iPad and iPod touch and has been translated into several languages (English, Galician, Arab, etc.). This application has topped the 20,000 downloads from App Store--mainly from Spain and the USA--since its release. Picaa is a system designed for the ...

New knowledge about the remarkable properties of black holes

2012-12-11

Black holes are surrounded by many mysteries, but now researchers from the Niels Bohr Institute, among others, have come up with new groundbreaking theories that can explain several of their properties. The research shows that black holes have properties that resemble the dynamics of both solids and liquids. The results are published in the prestigious scientific journal, Physical Review Letters. Black holes are extremely compact objects in the universe. They are so compact that they generate an incredibly strong gravitational pull and everything that comes near them ...

Anti-aging gene identified as tumor suppressor in mice, research finds

2012-12-11

ANN ARBOR, Mich. — A new study sheds more light on how an anti-aging gene suppresses cancer growth, joint University of Michigan Health System and Harvard Medical School research shows. Loss of the SIRT6 protein in mice increases the number, size and aggressiveness of tumors, according to the new research published in the scientific journal Cell. The study also suggests that the loss of SIRT6 promotes tumor growth in human colon and pancreatic cancers. "It is critical to understand the spectrum of genes that suppress tumor development," says co-senior author David Lombard, ...

Salmonella spreads by targeting cells in our gut, study shows

2012-12-11

Researchers have found that the bacteria are able to change key cells that line the intestine, enabling the bugs to thrive. By changing the make-up of these cells, the salmonella bacteria are able to cross the gut wall and infect vital organs, such as the kidneys and the liver. Salmonella food poisoning – commonly caused by eating undercooked poultry or eggs – can lead to diarrhoea, fever and even death in young children. Scientists say the study furthers our understanding of how bacterial infections occur and what enables them to spread. The University of Edinburgh ...

Alternative to fullerenes in organic solar cells -- just as exciting

2012-12-11

An insight into the properties of fullerene is set to open the door to a new class of electronic acceptors which can be used to build better and cheaper organic solar cells. Organic solar cells have advanced a great deal since they were first invented nearly 20 years ago, but the fullerene component has remained largely the same and this has had a braking effect on the evolution of the technology. But now scientists at the University of Warwick have pinpointed an unappreciated property of fullerenes, namely the availability of additional electron accepting states, which ...

RI Hospital: Borderline personality, bipolar disorders have similar unemployment rates

2012-12-11

PROVIDENCE, R.I. – Unemployment poses a significant burden on the public no matter what the cause. But for those who have been diagnosed with a psychiatric illness, chronic unemployment is often coupled with significant health care costs. A Rhode Island Hospital study compared unemployment rates among those with various psychiatric disorders, and found that borderline personality disorder is associated with as much unemployment as bipolar disorder. Researcher Mark Zimmerman, M.D., the director of outpatient psychiatry at Rhode Island Hospital, and his colleagues studied ...

Children born prematurely are at higher risk of esophageal inflammation, cancer

2012-12-11

Infants that are born preterm or with impaired growth have an increased risk of developing gastroesophageal reflux disease (GERD), possibly leaving them vulnerable to the development of esophageal adenocarcinoma later in life. Gestational age and size at birth affect the risk of an early diagnosis of esophagitis — inflammation of the esophagus — according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. "Long-term exposure to reflux is a major risk factor for esophageal ...

Tiotropium has advantages for patients with COPD

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: